Linynsky Laura A

SEC Form 4 insider trading activity

Linynsky Laura A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.

On the most recent filing, Linynsky Laura A is listed as Director at Pediatrix Medical Group, Inc. Inside the rolling window, Linynsky Laura A reported no open-market purchases and 1 open-market sale totaling $217K in MD.

Companies traded

Other insiders at MD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$217K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MD
Linynsky Laura A
Sale$217KNov 10SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Linynsky Laura A made?

Linynsky Laura A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.

Which companies does Linynsky Laura A trade?

Linynsky Laura A has filed SEC Form 4 disclosures for 1 company, including MD.

When was Linynsky Laura A's most recent SEC Form 4 filing?

Linynsky Laura A's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.

What is Linynsky Laura A's total buy and sell value in the current window?

Inside the rolling retention window, Linynsky Laura A bought $0 and sold $217K based on SEC Form 4 filings.

What was Linynsky Laura A's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 MD shares on 2025-11-06, worth $217K, per SEC Form 4 filings.